Back to Search Start Over

Risankizumab vs. adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal.

Authors :
Al-Janabi A
Warren RB
Source :
The British journal of dermatology [Br J Dermatol] 2020 Aug; Vol. 183 (2), pp. 220-221. Date of Electronic Publication: 2020 Feb 13.
Publication Year :
2020

Subjects

Subjects :
Adalimumab therapeutic use
Humans
Severity of Illness Index
Treatment Outcome
Antibodies, Monoclonal
Psoriasis drug therapy

Details

Language :
English
ISSN :
1365-2133
Volume :
183
Issue :
2
Database :
MEDLINE
Journal :
The British journal of dermatology
Publication Type :
Academic Journal
Accession number :
31899817
Full Text :
https://doi.org/10.1111/bjd.18856
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details